TOMASSINI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.661
EU - Europa 298
AS - Asia 186
SA - Sud America 17
AF - Africa 5
Totale 2.167
Nazione #
US - Stati Uniti d'America 1.653
IT - Italia 92
IN - India 66
SG - Singapore 65
SE - Svezia 52
CN - Cina 42
UA - Ucraina 40
FI - Finlandia 39
GB - Regno Unito 17
AR - Argentina 16
BG - Bulgaria 11
DE - Germania 10
NL - Olanda 7
AT - Austria 6
BE - Belgio 6
CA - Canada 5
IE - Irlanda 5
RO - Romania 4
IR - Iran 3
KR - Corea 3
TG - Togo 3
CH - Svizzera 2
DK - Danimarca 2
FR - Francia 2
KZ - Kazakistan 2
MX - Messico 2
TR - Turchia 2
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
LV - Lettonia 1
MM - Myanmar 1
PA - Panama 1
TW - Taiwan 1
Totale 2.167
Città #
Fairfield 311
Chandler 154
Woodbridge 127
Ashburn 112
Seattle 105
Cambridge 98
Wilmington 96
Houston 91
Ann Arbor 58
Singapore 44
Princeton 41
Rome 36
San Paolo di Civitate 36
Plano 35
Dearborn 31
Boston 28
Lawrence 28
Beijing 23
Federal 16
Andover 15
Jacksonville 14
San Diego 13
New York 11
Sofia 11
Boardman 10
Millbury 10
Falls Church 9
Norwalk 8
Helsinki 7
Brussels 6
Hefei 6
Vienna 6
Amsterdam 5
Dublin 5
Edinburgh 4
Santa Clara 4
Verona 4
Lomé 3
Mannheim 3
Phoenix 3
San Mateo 3
Toronto 3
Bern 2
Bühl 2
Chicago 2
Conegliano 2
Copenhagen 2
Frankfurt am Main 2
Guangzhou 2
Laurel 2
London 2
Nanchang 2
Ningbo 2
Ottawa 2
Philadelphia 2
Redmond 2
Ridder 2
San Jose 2
Torino 2
Algiers 1
Asso 1
Atlanta 1
Bergamo 1
Bremen 1
Budapest 1
Buffalo 1
Cairo 1
Changsha 1
Charlotte 1
Civitavecchia 1
Dallas 1
Des Moines 1
Fasano 1
Formello 1
Fort Worth 1
Grammichele 1
Hangzhou 1
Hounslow 1
Jinan 1
Kish 1
Kunming 1
Leawood 1
Los Angeles 1
Mcallen 1
Mexico City 1
Mumbai 1
Naaldwijk 1
Nanjing 1
Nay Pyi Taw 1
Panama City 1
Paris 1
Prescot 1
Riga 1
Riva 1
Shenyang 1
Taipei 1
Tallinn 1
Tappahannock 1
Tel Aviv 1
Washington 1
Totale 1.708
Nome #
6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with Interferon-beta. 93
Diffusion-weighted Imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations 87
Psychopathological and Cognitive Effects of Therapeutic Cannabinoids in Multiple Sclerosis: A Double-Blind, Placebo Controlled, Crossover Study. 85
Effect on cognition of estroprogestins combined with Interferon Beta in multiple sclerosis: analysis of secondary outcomes from a randomised controlled trial 82
Alexithymia in multiple sclerosis: relationship with fatigue and depression 78
Cannabinoid-induced effects on the nociceptive system: A neurophysiological study in patients with secondary progressive multiple sclerosis 74
"Gender Gap" in multiple sclerosis: magnetic resonance imaging evidence. 73
Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial 70
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 70
Interferon beta treatment of MS in the daily clinical setting: a 3-year post-marketing study 69
Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. 68
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple Sclerosis. 68
PREDICTORS OF LONG-TERM CLINICAL RESPONSE TO INTERFERON BETA THERAPY IN RELAPSING MULTIPLE SCLEROSIS. 68
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS 67
Sex hormones modulate brain damage in multiple sclerosis: MRI evidence 65
Treatment of multiple sclerosis-related fatigue: pharmacological and non-pharmacological approaches 65
Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment 65
null 64
Sex hormones, brain damage and clinical course of Multiple Sclerosis 61
Neutralizing antibodies explain the poor clinical response to Interferon beta in a small proportion of patients with Multiple Sclerosis: A retrospective study 59
Evidence of Impaired Brain Activity Balance after Passive Sensorimotor Stimulation in Multiple Sclerosis 59
Relationship between prolactin plasma levels and white matter volume in women with multiple sclerosis 58
Predicting the profile of increasing disability in multiple sclerosis 58
Oral contraceptives combined with interferon β in multiple sclerosis 56
Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis 52
Structural and functional bases for individual differences in motor learning 50
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride. 49
null 46
Predictors of training-related improvement in visuomotor performance in patients with multiple sclerosis: A behavioural and MRI study 42
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 42
Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis 40
Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis. 37
Medical education and MS: getting the training right. 36
Combining MRI activity with markers of myelin damage in clinically isolated syndrome suggestive of multiple sclerosis 34
Increased functional connectivity of multiple resting state networks after motor training in multiple sclerosis. 33
Impaired Functional Connectivity Unmasked by Simple Repetitive Motor Task in Early Relapsing-Remitting Multiple Sclerosis.Neurorehabil Neural Repair. 2014 Nov 21. pii: 1545968314558600. 28
Relationship between regional corpus callous atrophy and Paced Auditory Serial Addition test in multiple sclerosis 27
null 22
Evidence of impaired brain activity balance after passive sensorimotor stimulation in multiple sclerosis. PLoS One. 2013 Jun 14;8(6):e65315. doi: 10.1371/journal.pone.0065315. Print 2013. 17
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence 16
Totale 2.233
Categoria #
all - tutte 5.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.815


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020454 0 0 3 27 55 79 80 70 66 31 29 14
2020/2021152 20 23 10 13 1 3 1 34 23 13 10 1
2021/2022430 3 26 45 5 48 11 10 38 37 26 97 84
2022/2023480 78 84 10 69 70 37 8 38 48 1 33 4
2023/2024142 13 28 3 13 7 21 1 8 0 25 16 7
2024/202545 6 26 13 0 0 0 0 0 0 0 0 0
Totale 2.233